Revolution Medicines Inc (NASDAQ: RVMD) open the trading on Wednesday, with great promise as it jumped 1.55% to $38.75, before settling in for the price of $38.16 at the close. Taking a more long-term approach, RVMD posted a 52-week range of $29.55-$62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -38.52%. Meanwhile, its Annual Earning per share during the time was -27.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -26.56%. This publicly-traded company’s shares outstanding now amounts to $185.90 million, simultaneously with a float of $161.71 million. The organization now has a market capitalization sitting at $7.20 billion. At the time of writing, stock’s 50-day Moving Average stood at $40.89, while the 200-day Moving Average is $44.65.
Revolution Medicines Inc (RVMD) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Revolution Medicines Inc’s current insider ownership accounts for 13.02%, in contrast to 94.01% institutional ownership. According to the most recent insider trade that took place on Mar 17 ’25, this organization’s General Counsel sold 1,458 shares at the rate of 39.04, making the entire transaction reach 56,921 in total value, affecting insider ownership by 59,764. Preceding that transaction, on Mar 17 ’25, Company’s insider sold 11,738 for 39.04, making the whole transaction’s value amount to 458,255. This particular insider is now the holder of 441,564 in total.
Revolution Medicines Inc (RVMD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.07 per share during the current fiscal year.
Revolution Medicines Inc’s EPS decrease for this current 12-month fiscal period is -26.56% and is forecasted to reach -4.91 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.88% through the next 5 years, which can be compared against the -27.80% growth it accomplished over the previous five years trading on the market.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Let’s observe the current performance indicators for Revolution Medicines Inc (RVMD). It’s Quick Ratio in the last reported quarter now stands at 14.20. The Stock has managed to achieve an average true range (ATR) of 1.64.
In the same vein, RVMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.57, a figure that is expected to reach -1.08 in the next quarter, and analysts are predicting that it will be -4.91 at the market close of one year from today.
Technical Analysis of Revolution Medicines Inc (RVMD)
[Revolution Medicines Inc, RVMD] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 53.85% While, its Average True Range was 1.59.
Raw Stochastic average of Revolution Medicines Inc (RVMD) in the period of the previous 100 days is set at 9.99%, which indicates a major fall in contrast to 49.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 52.56% that was higher than 44.17% volatility it exhibited in the past 100-days period.
